Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4uof | DAT | Nucleoside diphosphate kinase |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4uof | DAT | Nucleoside diphosphate kinase | / | 1.000 | |
| 4uog | YYY | Nucleoside diphosphate kinase | / | 0.678 | |
| 4uoh | ADP | Nucleoside diphosphate kinase | / | 0.607 | |
| 4fkx | CDP | Nucleoside diphosphate kinase | / | 0.573 | |
| 1zs6 | ADP | Nucleoside diphosphate kinase 3 | 2.7.4.6 | 0.569 | |
| 2hve | ADP | Nucleoside diphosphate kinase A | 2.7.4.6 | 0.550 | |
| 3bbf | GDP | Nucleoside diphosphate kinase B | 2.7.4.6 | 0.549 | |
| 1nue | GDP | Nucleoside diphosphate kinase B | 2.7.4.6 | 0.542 | |
| 1wkl | ATP | Nucleoside diphosphate kinase | / | 0.516 | |
| 2hvd | ADP | Nucleoside diphosphate kinase A | 2.7.4.6 | 0.516 | |
| 3ngu | ADP | Nucleoside diphosphate kinase | / | 0.513 | |
| 2dxe | GDP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.489 | |
| 3q8u | ADP | Nucleoside diphosphate kinase | / | 0.488 | |
| 2dxf | GNP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.484 | |
| 2dy9 | ADP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.483 | |
| 1ndc | TYD | Nucleoside diphosphate kinase, cytosolic | 2.7.4.6 | 0.476 | |
| 2az3 | CDP | Nucleoside diphosphate kinase | / | 0.475 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.475 | |
| 1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.471 | |
| 5h8t | RTL | Retinol-binding protein 1 | / | 0.467 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.466 | |
| 3up0 | D7S | aceDAF-12 | / | 0.465 | |
| 2ddo | ATP | Pyridoxine/pyridoxal/pyridoxamine kinase | / | 0.461 | |
| 5iqa | GNP | Bifunctional AAC/APH | 2.3.1 | 0.461 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.460 | |
| 2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
| 5iqb | GNP | Bifunctional AAC/APH | 2.3.1 | 0.460 | |
| 1s19 | MC9 | Vitamin D3 receptor | / | 0.459 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.459 | |
| 1lwx | AZD | Nucleoside diphosphate kinase, cytosolic | 2.7.4.6 | 0.458 | |
| 1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
| 2dxd | ANP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.458 | |
| 5iqi | GNP | Bifunctional AAC/APH | 2.3.1 | 0.458 | |
| 4wdf | A2P | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.456 | |
| 1bux | PPS | Nucleoside diphosphate kinase, cytosolic | 2.7.4.6 | 0.455 | |
| 1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
| 1sd2 | MTH | S-methyl-5'-thioadenosine phosphorylase | / | 0.453 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
| 1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
| 3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.451 | |
| 1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
| 4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.450 | |
| 4hr2 | ADP | Nucleoside diphosphate kinase | / | 0.450 | |
| 2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.449 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.449 | |
| 3dds | 26B | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.447 | |
| 1crb | RTL | Retinol-binding protein 1 | / | 0.446 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.446 | |
| 3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.445 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.445 | |
| 4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.445 | |
| 1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.444 | |
| 2har | OCC | Vitamin D3 receptor | / | 0.444 | |
| 3jun | AKD | Phenazine biosynthesis protein A/B | / | 0.444 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.444 | |
| 2c94 | TSF | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.443 | |
| 3gi2 | GHW | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4g1y | 0VO | Vitamin D3 receptor A | / | 0.443 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 2ydb | NAP | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.442 | |
| 4kp6 | 1S1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.442 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.441 | |
| 1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.441 | |
| 2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.441 | |
| 2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 2vcx | D26 | Hematopoietic prostaglandin D synthase | / | 0.441 | |
| 3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.441 | |
| 4g20 | 484 | Vitamin D3 receptor A | / | 0.441 | |
| 1dli | UDX | UDP-glucose 6-dehydrogenase | / | 0.440 | |
| 1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 3up3 | XCA | aceDAF-12 | / | 0.440 | |
| 4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4die | C5P | Cytidylate kinase | / | 0.440 | |
| 4g2h | 0VQ | Vitamin D3 receptor A | / | 0.440 | |
| 4g2w | NI0 | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.440 | |
| 5doz | NDP | JamJ | / | 0.440 |